Three salvianolic acids inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2
S Hu, J Wang, Y Zhang, H Bai, C Wang… - Journal of medical …, 2021 - Wiley Online Library
Since December 2019, the new coronavirus (also known as severe acute respiratory
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …
Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
S Hu, J Wang, Y Zhang, H Bai, C Wang… - Journal of Medical …, 2021 - europepmc.org
Since December 2019, the new coronavirus (also known as severe acute respiratory
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …
Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2
S Hu, J Wang, Y Zhang, H Bai… - Journal of medical …, 2021 - pubmed.ncbi.nlm.nih.gov
Since December 2019, the new coronavirus (also known as severe acute respiratory
syndrome coronavirus 2 [SARS-CoV-2, 2019-nCoV])-induced disease, COVID-19, has …
syndrome coronavirus 2 [SARS-CoV-2, 2019-nCoV])-induced disease, COVID-19, has …
[HTML][HTML] Three salvianolic acids inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2
S Hu, J Wang, Y Zhang, H Bai, C Wang… - Journal of Medical …, 2021 - ncbi.nlm.nih.gov
Since December 2019, the new coronavirus (also known as severe acute respiratory
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …
Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
S Hu, J Wang, Y Zhang, H Bai, C Wang, N Wang, L He - 2021 - cabidigitallibrary.org
Since December 2019, the new coronavirus (also known as severe acute respiratory
syndrome coronavirus 2 [SARS-CoV-2, 2019-nCoV])-induced disease, COVID-19, has …
syndrome coronavirus 2 [SARS-CoV-2, 2019-nCoV])-induced disease, COVID-19, has …
Three salvianolic acids inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2
S Hu, J Wang, Y Zhang, H Bai, C Wang… - Journal of Medical …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Since December 2019, the new coronavirus
(also known as severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2, 2019 …
(also known as severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2, 2019 …
Three salvianolic acids inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2
S Hu, J Wang, Y Zhang, H Bai, C Wang… - Journal of Medical …, 2021 - infona.pl
Since December 2019, the new coronavirus (also known as severe acute respiratory
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …
Three salvianolic acids inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
S Hu, J Wang, Y Zhang, H Bai… - Journal of Medical …, 2021 - search.ebscohost.com
Since December 2019, the new coronavirus (also known as severe acute respiratory
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …
syndrome coronavirus 2 [SARS‐CoV‐2, 2019‐nCoV])—induced disease, COVID‐19, has …